CION Ameerpet
Genetics Explained · Reviewed by CION Oncologists · NABH Accredited
Could Your Endometrial Cancer Be Lynch-Related?
If you have been told your tumour showed an abnormal MMR result, you may have gone straight to a frightening conclusion about your children. Slow down, because that result on its own does not mean you have Lynch syndrome — and most of the time it means something else entirely. Mismatch repair deficiency is common in endometrial cancer, and the majority of it is an acquired change that happened inside the tumour, carrying no implications for anyone in your family. This page explains which features genuinely point towards an inherited cause, and what the sequence of tests is actually establishing.
- An abnormal MMR result is a screen, not a diagnosis — it is the first step, not the answer
- Most abnormal results are acquired — a change within the tumour, not something inherited
- Age and family pattern matter — diagnosis under 50, or bowel cancer in the family
- It is worth resolving properly — because a true Lynch result changes things for your relatives
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The Testing Sequence, and What Each Step Answers
Three steps, and they answer three different questions. Confusing the first with the third is the source of most of the distress on this subject.
- Step one — MMR testing on the tumour. Immunohistochemistry looks for the four mismatch repair proteins in the tumour tissue. If one or more is missing, the tumour is mismatch repair deficient. Question answered: is the repair system working in this tumour? This is done on every endometrial cancer. See MMR and MSI testing.
- Step two — MLH1 methylation testing. Performed when the missing protein is MLH1, which is the commonest pattern. It distinguishes an acquired silencing of the gene within the tumour from a possible inherited fault. Question answered: is there an ordinary explanation that rules out inheritance? If methylation is present, that is usually the end of it.
- Step three — germline genetic testing. A blood test looking at the genes in your normal cells rather than in the tumour. Question answered: were you born with this? Only this step can diagnose Lynch syndrome, and it is arranged through genetic counselling. See genetic testing for Lynch syndrome.
Most women stop at step one with a normal result, or at step two with methylation found. Only a minority reach step three, and only a minority of those turn out to carry an inherited variant.
Did You Know? Roughly a quarter to a third of endometrial cancers show mismatch repair deficiency — and only a small fraction of those turn out to be Lynch syndrome. The commonest explanation is entirely different: the tumour has silenced one of its own repair genes through a chemical change called MLH1 promoter methylation. That happens within the tumour during a woman’s life, is not present in the rest of her body, and cannot be passed to anyone. This is precisely why an MLH1 methylation test is performed before any genetic testing is considered. A woman told her tumour was “MMR deficient” and left to assume the worst has usually been given half a result. Sources: NCCN Clinical Practice Guidelines in Oncology — Genetic/Familial High-Risk Assessment: Colorectal, Endometrial and Gastric, and Uterine Neoplasms; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Features That Raise Suspicion
None of these is diagnostic on its own. Together they are what prompts a genetic counselling referral even when the tumour testing is not clear-cut.
| Feature | Why it points that way |
|---|---|
| Diagnosis under 50 | Sporadic endometrial cancer is overwhelmingly postmenopausal. A woman diagnosed in her forties, particularly without the usual risk factors, is a recognised trigger for considering an inherited cause. |
| Bowel cancer in the family | The strongest family signal, because colorectal and endometrial cancer are the two Lynch syndrome most commonly causes. More informative than other cases of womb cancer. See family history. |
| You have had another primary cancer | Particularly bowel or ovarian. A woman with two separate primary cancers is a strong signal in her own right, even with no affected relatives. |
| Tumour in the lower uterine segment | Cancers arising low in the body of the uterus, near the cervix, are over-represented in Lynch syndrome. A pathological detail rather than something you would notice. |
| Loss of MSH2, MSH6 or PMS2 | When the missing protein is one of these rather than MLH1, an acquired methylation explanation does not apply in the same way, and germline testing generally follows directly. |
| MLH1 lost but no methylation found | The pattern that most often leads onward. It means the ordinary acquired explanation has been looked for and not found, so an inherited cause has to be excluded. |
| A slim woman with regular cycles | Not diagnostic, but worth noting. Endometrial cancer in a woman without any of the usual hormonal risk factors invites the question of what else might be driving it. |
If you are unsure what your tumour testing showed, ask for it specifically. The useful question is: “Which mismatch repair proteins were lost, and was MLH1 methylation tested?” Those two facts determine everything that follows, and they are on a report that already exists.
Told Your Tumour Was “MMR Deficient” and Left Worrying?
That is half a result. We will explain what it means, whether methylation was tested, and whether anything further is warranted.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
An Abnormal Tumour Result Is Not a Family Diagnosis
Most mismatch repair deficiency in endometrial cancer is acquired and carries no implications for your relatives.
Why It Is Worth Resolving Either Way
Some women decide they would rather not know, and that is a legitimate position that genetic counselling is designed to explore rather than override. It is worth understanding what is on the other side of the decision.
- For you: bowel screening. This is the largest practical benefit. Lynch syndrome carries a substantially raised risk of colorectal cancer, and regular colonoscopy is highly effective there because polyps can be removed before they become cancers. In many women, endometrial cancer is the first Lynch cancer — so a diagnosis now is an opportunity to prevent the next one.
- For you: other cancers. Ovarian, gastric and urinary tract cancers occur at raised frequency, and knowing changes what symptoms get investigated and how quickly.
- For you: treatment. Mismatch repair deficient tumours respond notably well to checkpoint immunotherapy, so the same finding is relevant to your own care if disease ever recurs. See immunotherapy.
- For your family: this is the main reason. Each first-degree relative has a substantial chance of carrying the same variant, and testing is straightforward once the family variant is known. Relatives who test positive enter surveillance before any cancer develops. See Lynch syndrome and your family.
For how the two cancers relate in practice, and what a woman with Lynch syndrome faces across both, see endometrial and colorectal cancer together.
Want the Genetics Side Sorted Out Properly?
What your tumour testing showed, whether anything further is warranted, and what it would mean for your family. The opinion is free.
Four Misunderstandings Worth Clearing Up
These come up in almost every consultation on this subject.
“MMR deficient means I have Lynch syndrome”
It does not. Mismatch repair deficiency is found in roughly a quarter to a third of endometrial cancers, and the majority reflects MLH1 promoter methylation — an acquired change inside the tumour that is not present in the rest of your body and cannot be inherited by anyone. The tumour test is a screen designed to catch everyone who might have Lynch syndrome, which necessarily means most positives are not.
“Nobody in my family had cancer, so it cannot be inherited”
Family history is helpful when present but its absence proves little. Small families, families with few women, families where relatives died young of other causes, and transmission through a father who never developed a cancer himself all produce an unremarkable-looking history. This is a large part of why universal tumour testing was introduced rather than relying on family history to select who gets tested.
“If I have Lynch syndrome, my cancer is worse”
Not so. Mismatch repair deficient endometrial cancers are frequently diagnosed at an early stage, and the same biology that defines them makes them unusually responsive to checkpoint immunotherapy if advanced disease ever develops. The significance of a Lynch diagnosis lies overwhelmingly in future risk — to your bowel, and to your relatives — rather than in the outlook for the cancer you already have.
“A genetic test would tell me straight away”
Sometimes, and not always. Germline testing can return a clear pathogenic variant, a clear negative, or a variant of uncertain significance — a change whose meaning is not yet known. The last is genuinely unsettling and is one of the main reasons testing is arranged through counselling, where the possible outcomes including that one are explained before the blood is taken rather than afterwards.
Why This Should Not Be Left Half-Explained
A woman told her tumour was abnormal, without being told what that does and does not mean, carries an unnecessary fear.
MMR / MSI testing as standard
Lynch counselling built in
Slides reviewed, not just the summary line
Tumour board for every diagnosis
45-minute consultations
Decisions for healing, not billing
Take The Next Step
Ask What Your Tumour Testing Actually Showed
Which proteins were lost, and whether methylation was tested. Those two facts decide everything else.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Lynch-Related Endometrial Cancer — Frequently Asked Questions
My tumour was MMR deficient. Does that mean I have Lynch syndrome?
No — it means a screening test was positive and further testing is needed to find out. Mismatch repair deficiency is found in roughly a quarter to a third of endometrial cancers, and only a small fraction of those turn out to be Lynch syndrome. The commonest explanation is entirely different: the tumour has silenced one of its own repair genes through a chemical change called MLH1 promoter methylation, which happens within the tumour during life, is not present in the rest of your body, and cannot be passed to anyone. That is why an MLH1 methylation test is done before genetic testing is considered. Ask which proteins were lost and whether methylation was tested.
What features suggest my endometrial cancer might be inherited?
Several, and they are considered together rather than individually. Being diagnosed under fifty is a recognised trigger, since sporadic endometrial cancer is overwhelmingly postmenopausal. A family history combining bowel and womb cancer is the strongest family signal — more informative than other cases of womb cancer alone. Having had another primary cancer yourself, particularly bowel or ovarian, is a strong signal even without affected relatives. On the pathology side, a tumour arising low in the uterus near the cervix is over-represented in Lynch syndrome, as is loss of MSH2, MSH6 or PMS2 rather than MLH1. Absence of the usual hormonal risk factors also invites the question.
Nobody in my family has had cancer. Can I still have Lynch syndrome?
Yes, and this is why universal tumour testing was introduced rather than relying on family history to decide who gets tested. An unremarkable family history is produced by many ordinary situations: small families, families with few women, relatives who died young of other causes before a cancer could develop, and transmission through a father who carries the variant but never developed a cancer himself. Lynch syndrome is inherited in an autosomal dominant pattern, passing equally through either parent, so taking only the maternal history misses cases. A reassuring family history is genuinely reassuring but it is not conclusive.
Does having Lynch syndrome make my cancer harder to treat?
No, and if anything the opposite. Mismatch repair deficient endometrial cancers are frequently diagnosed at an early stage, and the same biology that defines them — a very high number of mutations making the tumour visible to the immune system — makes them unusually responsive to checkpoint inhibitor immunotherapy should advanced or recurrent disease ever develop. The significance of a Lynch diagnosis lies almost entirely in future risk rather than in the cancer you already have: raised lifetime risk of colorectal and other cancers for you, and the implications for relatives who may carry the same variant.
If it turns out to be Lynch syndrome, what actually changes?
Four things. You would be offered regular colonoscopy from a younger age, which is the largest practical benefit — colorectal cancer risk is substantial in Lynch syndrome and colonoscopy is highly effective there because polyps can be removed before they become cancers. Awareness of raised risk of ovarian, gastric and urinary tract cancers changes what symptoms get investigated and how quickly. The mismatch repair finding is relevant to your own treatment if disease recurs. And your first-degree relatives can be tested straightforwardly once the family variant is known, with those who test positive entering surveillance before any cancer develops.
Medical disclaimer: This page explains how Lynch syndrome is identified in women with endometrial cancer and is reviewed by a CION oncologist, following current NCCN guidance on genetic and familial high-risk assessment and ESGO–ESTRO–ESP guidelines. An abnormal mismatch repair result on tumour testing does not establish a diagnosis of Lynch syndrome. It is general health information rather than an interpretation of your own results, and genetic testing should be arranged through genetic counselling.